医学
淋巴瘤
边缘地带
放射治疗
化疗
疾病
病理
放射科
B细胞
内科学
免疫学
抗体
作者
Keisuke Sasai,H Yamabe,Yukio Dodo,S. Kashii,Yuuya Nagata,M. Hiraoka
出处
期刊:Acta Oncologica
[Taylor & Francis]
日期:2001-06-01
卷期号:40 (4): 485-490
被引量:60
标识
DOI:10.1080/028418601750288217
摘要
This study investigates the relationship between the clinical features of lymphoma in the ocular adnexal region and the revised European and American lymphoma (REAL) classification. Specimens from 41 patients with ocular adnexal lymphoproliferative disease were reassessed pathologically using the REAL classification. Thirty-two patients with primary non-Hodgkin's lymphomas (NHL) were included in the study, almost all of them having been treated with radiotherapy with or without chemotherapy. Seven of the 32 patients with NHL showed distant recurrence after treatment: 3 out of 26 with extranodal marginal zone B-cell lymphoma, and 4 with other types of NHL. Although the three patients with recurrent marginal zone B-cell lymphomas all survived, other patients with recurrent lymphomas died of disease. The REAL classification provides a good indication of tumor control probability and survival of patients with ocular adnexal NHL. Radiation therapy is an effective treatment modality for extranodal marginal zone B-cell lymphoma of the ocular adnexa.
科研通智能强力驱动
Strongly Powered by AbleSci AI